IMR-1
IMR-1 is a novel class of Notch inhibitor targeting the transcriptional activation with an IC50 of 26 μM. IMR-1 prevents the recruitment of Mastermind-like 1 (Maml1) to the Notch Ternary Complex (NTC) on chromatin, inhibits Notch target gene transcription and dramatically inhibits tumor growth[1].
Product Specifications
CAS Number
[310456-65-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Notch
Type
Reference compound
Related Pathways
Neuronal Signaling; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/IMR-1.html
Purity
98.95
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(OCC)COC1=CC=C(/C=C(SC(N2)=S)\C2=O)C=C1OC
Molecular Formula
C15H15NO5S2
Molecular Weight
353.41
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DSTYK (Dual Serine/Threonine and Tyrosine Protein Kinase, Dusty Protein Kinase, Dusty PK, RIP-Homologous Kinase, Receptor-interacting Serine/Threonine-Protein Kinase 5, Sugen Kinase 496, SgK496, DSTYK, KIAA0472, RIP5, RIPK5, SGK496) (APC) discontinued
PLAT, Recombinant, Human, aa311-556, His-SUMO-Tag (Tissue-type Plasminogen Activator)
PLAT, Recombinant, Human, aa311-556, His-SUMO-Tag (Tissue-type Plasminogen Activator)
PLAT, Recombinant, Human, aa311-556, His-SUMO-Tag (Tissue-type Plasminogen Activator)